Mid-Day Commentary & Reports for : (NASDAQ: PPHM), (NYSE: STP)
New York, NY -- (SBWIRE) -- 01/08/2013 -- Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company engaged in the research and development of monoclonal antibodies for the treatment and diagnosis of cancer and viral infections, is down in trading today, following the huge rally in the previous trading session.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here